Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
neurological disorder
|
| gptkbp:affects |
peripheral nervous system
|
| gptkbp:alsoKnownAs |
gptkb:Miller_Fisher_syndrome
|
| gptkbp:associatedWithAntibody |
anti-GQ1b antibody
|
| gptkbp:cause |
autoimmune response
|
| gptkbp:characterizedBy |
ataxia
areflexia ophthalmoplegia |
| gptkbp:diagnosedBy |
clinical examination
nerve conduction studies cerebrospinal fluid analysis |
| gptkbp:firstDescribed |
gptkb:Charles_Miller_Fisher
1956 |
| gptkbp:frequency |
rare
|
| https://www.w3.org/2000/01/rdf-schema#label |
Fisher syndrome
|
| gptkbp:ICD-10_code |
G61.81
|
| gptkbp:partOf |
Guillain-Barré syndrome spectrum
|
| gptkbp:prognosis |
generally good
|
| gptkbp:relatedTo |
gptkb:Guillain-Barré_syndrome
|
| gptkbp:symptom |
double vision
unsteady gait loss of deep tendon reflexes |
| gptkbp:treatment |
intravenous immunoglobulin
plasmapheresis |
| gptkbp:triggeredBy |
preceding infection
|
| gptkbp:bfsParent |
gptkb:Charles_Miller_Fisher
|
| gptkbp:bfsLayer |
8
|